Certainly, the role of TLR4/MD-2 complex for activation of MyD88/NF-κB signaling needs to be further studied in a variety of ovarian cancer cell lines of different phenotypes, and even in vivo study. This evidence concerns the gene LY96 and ovarian carcinoma.